Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 6 studies | 28% ± 12% | |
goblet cell | 5 studies | 20% ± 3% | |
non-classical monocyte | 4 studies | 27% ± 6% | |
enterocyte | 4 studies | 18% ± 2% | |
epithelial cell | 4 studies | 26% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 5970.47 | 965 / 966 | 98% | 53.05 | 515 / 527 |
esophagus | 99% | 1693.62 | 1433 / 1445 | 94% | 29.43 | 172 / 183 |
kidney | 100% | 1908.49 | 89 / 89 | 89% | 34.04 | 805 / 901 |
bladder | 100% | 1918.90 | 21 / 21 | 88% | 24.56 | 445 / 504 |
lung | 99% | 1440.54 | 574 / 578 | 88% | 19.06 | 1020 / 1155 |
adrenal gland | 100% | 3585.67 | 258 / 258 | 87% | 18.57 | 199 / 230 |
uterus | 100% | 3545.99 | 170 / 170 | 83% | 14.21 | 381 / 459 |
breast | 95% | 1223.87 | 438 / 459 | 86% | 14.74 | 966 / 1118 |
stomach | 76% | 943.84 | 274 / 359 | 98% | 49.23 | 279 / 286 |
ovary | 100% | 4442.06 | 180 / 180 | 71% | 7.65 | 307 / 430 |
skin | 99% | 1519.42 | 1784 / 1809 | 62% | 8.23 | 292 / 472 |
brain | 70% | 447.75 | 1851 / 2642 | 78% | 12.43 | 551 / 705 |
thymus | 68% | 450.27 | 443 / 653 | 68% | 8.31 | 410 / 605 |
pancreas | 39% | 329.43 | 129 / 328 | 96% | 64.25 | 171 / 178 |
prostate | 100% | 1600.63 | 244 / 245 | 27% | 1.94 | 137 / 502 |
blood vessel | 100% | 3915.65 | 1335 / 1335 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.86 | 1 / 1 |
spleen | 95% | 734.48 | 228 / 241 | 0% | 0 | 0 / 0 |
adipose | 87% | 903.82 | 1049 / 1204 | 0% | 0 | 0 / 0 |
liver | 29% | 228.23 | 66 / 226 | 52% | 10.73 | 213 / 406 |
tonsil | 0% | 0 | 0 / 0 | 69% | 6.95 | 31 / 45 |
heart | 61% | 479.15 | 529 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 37% | 234.91 | 341 / 929 | 0% | 0 | 0 / 0 |
muscle | 15% | 80.37 | 124 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 5% | 0.43 | 4 / 80 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.25 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046856 | Biological process | phosphatidylinositol dephosphorylation |
GO_0005737 | Cellular component | cytoplasm |
GO_0070062 | Cellular component | extracellular exosome |
Gene name | MTMR11 |
Protein name | Myotubularin-related protein 11 (Cisplatin resistance-associated protein) (hCRA) (Inactive phosphatidylinositol 3-phosphatase 11) |
Synonyms | |
Description | |
Accessions | A4FU01 ENST00000439741.4 [A4FU01-1] ENST00000369140.7 [A4FU01-4] |